You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

101 search results for: patient burden

Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
expert video

Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria

Dermatology
Join Dr. Jason Hawkes in discussing the burden of CSU and how type 2 inflammation contributes to the development of chronic wheals (hives) and angioedema
View more
Why Is It Important to Assess Lung Function in Pediatric Severe Asthma <b>Patient</b>s?
expert video

Why Is It Important to Assess Lung Function in Pediatric Severe Asthma Patients?

Pulmonology
Prof. Monika Gappa presents the importance in assessment of lung function in pediatric patients alongside the associated patient burden.
View more
Pediatric EoE Disease <b>Burden</b> Infographic
Infographic

Pediatric EoE Disease Burden Infographic

Gastroenterology
Learn about pediatric EoE disease burden and why early identification is key for pediatric patients with EoE
View more
EoE <b>Burden</b> and Pathophysiology of Type 2 Inflammation
videoanimation

EoE Burden and Pathophysiology of Type 2 Inflammation

Gastroenterology
Learn about the significant burden that patients with EoE experience, and the role of type 2 inflammation in this chronic, progressive disease.
View more
IRS-ISIAN 2024 | The Underappreciated <b>Burden</b> of Smell Loss and Congestion in CRSwNP
expert video

IRS-ISIAN 2024 | The Underappreciated Burden of Smell Loss and Congestion in CRSwNP

Rhinology
Prof. Joaquim Mullol describes the burdens of smell loss and nasal congestion for patients with uncontrolled and/or severe CRSwNP.
View more
Multifaceted <b>Burden</b> of Pediatric EoE
expert video

Multifaceted Burden of Pediatric EoE

Gastroenterology
Hear from Prof. Papadopoulou as she discusses how EoE can impact different aspects of disease burden in pediatric patients and their caregivers.
View more
EAACI 2023 | Pediatric Type 2 Inflammatory Disease Progression
expert video

EAACI 2023 | Pediatric Type 2 Inflammatory Disease Progression

Type 2 Inflammation
Dr. Leonard Bacharier and Profs. Oscar Palomares and Stephan Weidinger explore shared features of type 2 pathophysiology in AD, asthma, and EoE, and disease burden in pediatric patients
View more
CRSwNP Significantly Affects the Quality of Life of CRSwNP <b>Patient</b>s
interactivity

CRSwNP Significantly Affects the Quality of Life of CRSwNP Patients

Rhinology
Explore the factors that contribute to the significant burden of CRSwNP on patient quality of life.
View more
Importance of Lung Function Assessment in Pediatric Asthma <b>Patient</b>s
videoanimation

Importance of Lung Function Assessment in Pediatric Asthma Patients

Pulmonology
Review the burden associated with lung function decline in pediatric patients with severe asthma, and the value of clinical lung function assessments.
View more
Beyond the Signs ​and Symptoms: ​The Developmental <b>Burden</b> of AD in Children
expert video

Beyond the Signs ​and Symptoms: ​The Developmental Burden of AD in Children

Dermatology
Highlights from the ESPD 2023 ADVENT symposium: Exploring burden and comorbidities associated with moderate-to-severe atopic dermatitis in children.
View more
ADVENT On Air | More Than Just Difficulty Swallowing: EoE <b>Burden</b> and Diagnosis
Podcast

ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and Diagnosis

Gastroenterology
Hear Dr. Wechsler and Prof. Bredenoord discuss the multifaceted burden of EoE and how to overcome challenges in identifying EoE in clinical practice.
View more
The Disease <b>Burden</b> of AD in Children and the Impact of Type 2 Comorbidities 
expert video

The Disease Burden of AD in Children and the Impact of Type 2 Comorbidities 

Dermatology
Multidimensional disease burden of atopic dermatitis in children from a real-world case study – Presentation from the ADVENT symposium at EAACI 2023.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: FranceChange country/region